Biotech

All Articles

8 months after a $213M fundraise, gene publisher Tome helps make decreases

.After increasing $213 million in 2023-- some of the year's most extensive exclusive biotech shots--...

BioMarin constructs officer crew along with biotech vets-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of notable leadership hirings, shootings as...

Biopharma Q2 VC attacked highest level because '22, while M&ampA reduced

.Financial backing backing right into biopharma rose to $9.2 billion across 215 handle the 2nd fourt...

Bicara, Zenas seek IPOs to drive late-phase possessions towards market

.Bicara Rehabs and also Zenas Biopharma have supplied new impetus to the IPO market along with filin...

Genentech to shut cancer immunology study division

.Genentech will definitely shut its cancer immunology research team, and also device head and also p...

Kezar falls solid cyst but to prove its truly worth in period 1 trial

.Kezar Life Sciences is falling its unpromising period 1 solid lump medication as the biotech goes a...

Acelyrin loses izokibep, dismisses 3rd of personnel

.Regardless of izokibep sustaining its own newly found winning touch in the facility, Acelyrin is no...

Rivus' stage 2 obesity-related heart failure test hits endpoint

.Rivus Pharmaceuticals has plumped up the prospects of its fat-busting, muscle-sparing medicine appl...

Ovid stops preclinical job, IV plan after soticlestat fall short

.Ovid Rehab presently exposed final month that it was trimming its head count as the provider gets t...

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston Seaport

.Eli Lilly has actually opened a $700 million R&ampD facility in the Boston Port, boosting its own R...